“I think there will likely be some kind of warning, restriction, or risk assessment. I don’t think it will just go back and say, ‘OK, everything is fine’ and be right back,” he added. “I think it will probably read, ‘OK, we’re going to use it. But be careful in these certain circumstances.'”
The Centers for Disease Control and Prevention and the Food and Drug Administration on Tuesday recommended discontinuing the use of the J&J shot because of concerns about rare but severe blood clots.
A CDC vaccine advisory panel will meet on Friday to discuss concerns about the vaccine. The panel met on Wednesday but delayed voting on whether and how the J&J can be capped based on gender or age.
When asked if the public will know at least something specific when the advisory board meets at the end of the week, Fauci replied, “I’m pretty sure of that.”
“I think we’ll know which direction we’re going by Friday. Hopefully we’ll get back on track,” said Fauci. “But I don’t think there will be anything beyond that. I hope not. I think not.”
On CBS News’ Face the Nation, Fauci said the labeling of the problem with the Johnson & Johnson vaccine demonstrated how effective the government is in tracking the safety of the vaccines used.
“One of the things that you can get out of all of this is that when the surveillance system, the CDC, and the FDA say something is safe, you can be sure that something is safe,” he said.